Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela

Cancer Causes and Control

Volumn 17, Issue 9, 2006, Pages 1183-1191

  Kato, Ikuko ^a,b   Canzian, Federico ^c,d   Franceschi, Silvia ^c   Plummer, Martyn ^c   Van Doorn, Leen Jan ^e   Lu, Yanhui ^c   Gioia Patricola, Lydie ^c   Vivas, Jorge ^f   Lopez, Gladys ^f   Severson, Richard K ^a,g   Schwartz, Ann G ^a,b   Muñoz, Nubia ^c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e DDL DIAGNOSTIC LABORATORY   (Netherlands)

^f Cancer Control Center of the Tachira State   (Venezuela)

^g WAYNE STATE UNIVERSITY   (United States)

Author keywords

Anti inflammatory cytokines; Genetic polymorphisms; Helicobacter pylori; Premalignant lesions; Stomach cancer

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DYSPLASIA; ENTEROPATHY; ENVIRONMENTAL FACTOR; FEMALE; FOOD INTAKE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFECTION RATE; INFLAMMATION; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRECANCER; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKING; STOMACH TUMOR; VENEZUELA;

ADULT; AGED; CYTOKINES; FEMALE; GASTRITIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-4; INTESTINES; LOGISTIC MODELS; MALE; METAPLASIA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS; PREVALENCE; RECEPTORS, INTERLEUKIN-4; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VENEZUELA;

EID: 33749132152     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-006-0060-4     Document Type: Article

References (44)

1. Arora S, Czinn SJ (2005) Vaccination as a method of preventing Helicobacter pylori-associated gastric cancer. Cancer Epidemiol Biomarkers Prev 14:1890-1891
2. IARC (1994) Schistosomes, Liver Flukes and Helicobacter Pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol 61. IARC, Lyon, France
3. Pisani P, Parkin DM, Muñoz N, Ferlay J (1997) Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6:387-400
4. Correa P, Haenszel W, Cuello C, et al (1990) The gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 50:4731-4736
5. Opal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117:1162-1172
6. Hamilton TA, Ohmori Y, Tebo J (2002) Regulation of chemokine expression by antiinflammatory cytokines. Immunol Res 25:229-245
7. Mueller TD, Zhang J-L, Sebald W, Duschl A (2002) Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochem Biophys Acta 1592:237-250
8. Muñoz N, Kato I, Peraza S, et al (1996) Prevalence of precancerous lesions of the stomach in Venezuela. Cancer Epidemiol Biomarkers Prev 5:41-46
9. Filipe MI, Jass JR (1986) Intestinal metaplasia subtypes and cancer risk. In: Filipe MI, Jass JR (eds) Gastric carcinoma. Churchill Livingstone, Edinburgh, pp 97-115
10. van Doorn LJ, Figueiredo C, Rossau R, et al (1998) Typing of the Helicobacter pylori vacA gene and detection of the cagA gene by PCR and reverse hybridization. J Clin Microbiol 36:1271-1276
11. van Doorn LJ, Figueiredo C, Sanna R, et al (1998) Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 36:2597-2603
12. van Doorn LJ, Figueiredo C, Sanna R, Blaser MJ, Quint WGV(1999) Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol 37:2306-2311
13. Lu Y, Gioia-Patricola L, Gomez JV et al (2005) Use of whole genome amplification to rescue DNA from plasma samples. Biotechniques 39:511-515
14. Kato I, Vivas J, Plummer M, et al (2004) Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 13:468-476
15. Allion PD (1999) Chapter 5: multinominal logit analysis. Logistic regression using the SAS system: theory and application. SAS Institute Inc., Cary, NC, pp 103-132
16. Wigginton JE, Cutler DJ, Abecasis GR (2005) A note on exact test of Hardy-Weinberg equilibrium. Am J Hum Genet 76:887-883
17. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW (1992) Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148:3618-3623
18. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8
19. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42:1101-1108
20. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30:526-530
21. Stanczuk GA, Sibanda EN, Perrey C, et al (2001) Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer 94:792-794
22. Shih CM, Lee YL, Chiou HL, et al (2006) The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 52:15-20
23. McCarron SL, Edwards S, Evans PR, et al (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62:3369-3372
24. Nieters A, Yuan JM, Sun CL, et al (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103:740-748
25. El-Omar EM, Rabkin CS, Gammon MD, et al (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124:1193-1201
26. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT (2003) Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 104:617-623
27. Lu W, Pan K, Zhang L, Lin D, Miao X, You W (2005) Genetic polymorphisms of interleukin (IL)-1B, IL1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in Chinese population. Carcinogenesis 26:631-636
28. Rad R, Dossumbekova A, Neu B, et al (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53:1082-1089
29. Zambon CF, Basso D, Navaglia F, et al (2005) Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29:141-152
30. Garza-Gonzalez E, Hold G, Perez-Perez GI, et al (2003) Role of polymorphism of certain cytokines in gastric cancer in Mexico. Preliminary results. Rev Gastroenterol Mex 68:107-112
31. Sicinschi LA, Lopez-Carrillo L, Camargo MC, et al (2006) Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int J Cancer 118:649-657
32. Lee JY, Kim HY, Kim KH, et al (2005) Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 225:207-214
33. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L (2005) Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 175:2684-2691
34. Ho LJ, Chang DM, Shiau HY, et al (2001) Aspirin differentially regulates endotoxin-induced IL-12 and TNF-alpha production in human dendritic cells. Scand J Rheumatol 30:346-352
35. Hida N, Shimoyama T Jr, Neville P, et al (1999) Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol 52:658-664
36. Arai N, Nomura D, Villaret D, et al (1989) Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 142:274-282
37. Shirakawa I, Deichmann KA, Izuhara I, Mao I, Adra CN, Hopkin JM (2000) Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 21:60-64
38. Klein W, Tromm A, Griga T, et al (2001) Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun 2:287-289
39. Aithal GP, Day CP, Leathart J, Daly AK, Hudson M (2001) Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun 2:44-47
40. Tsai M-H, Chen W-C, Tsai C-H, Hang L-W, Tsai F-J (2005) Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal 19:93-98
41. Wu X, Di Rienzo A, Ober C (2001) A population genetics study of single nucleotide polymorphisms in the interleukin 4 receptor α (IL4RA) gene. Genes Immun 2:128-134
42. Hackstein H, Hecker M, Kruse S, et al (2001) A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 53:264-269
43. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S (1999) Long-term exercise and atherogenic activity of blood mononuclear cells in person at risk of developing ischemic heart disease. JAMA 281:1722-1727
44. Lawrence T, Willoughby DA, Gilroy DW (2002) Antiinflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2:787-795